Rourea cuspidata:Chemical composition and hypoglycemic activity
- Author:
Laikowski M. Manuela
;
Souza M. Debora
;
Minetto Luciane
;
Girondi Natalia
;
Pires Camila
;
Alano Gisiele
;
Roesch-Ely Mariana
;
Tasso Leandro
;
Moura Sidnei
- Keywords:
Rourea cuspidata;
Diabetes;
Phytochemical characterization;
HRMS
- From:Asian Pacific Journal of Tropical Biomedicine
2017;7(8):712-718
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the antidiabetic effect of Rourea cuspidata hydroalcoholic stem extract in normal and streptozotocin-induced diabetic rats. Methods: In order to evaluate the chemical composition, different extracts from stem in ascending solvent order of polarity were prepared. The extracts were analyzed by high resolution mass spectrometry and 7 compounds were identified, including hyperin, an important and already reported active compound in the literature. Hyperin was also quantified by HPLC-UV in all the extracts. The hydroalcoholic stem extract (Ss5), which showed the highest concentration of hyperin, was administered to STZ-induced diabetes rats to evaluate the potential hypoglycemic activity. Total cholesterol, HDL, triglycerides, ALT and AST were also evaluated. In the present study, the effects of oral administration of hydroalcoholic stem extract (200 mg/kg b. wt.) for 28 days on the level of serum glucose, total cholesterol, HDL, triglycerides, aspartate amino transferase (AST) and alanine amino transferase (ALT) in normal and streptozotocin-induced diabetic rats were evaluated. Histopathological changes in diabetic rats' pancreas were also studied. Results: The extract exposition demonstrated hypoglycemic effect like the drug control glibenclamide. The extract was able to increase the HDL levels. Histopathological study on diabetic rats' pancreas after extract treatment showed morphological alterations in STZ-induced diabetes rats, which were apparently restored after extract treatment. Conclusions: This work demonstrates the potential use of R. cuspidata as hypoglycemic agent in the treatment of diabetes.
